The earnings call presented a generally positive outlook with strong organic growth and improved margins, despite significant headwinds from tariffs and FX. Regulatory and quality improvements, along with successful strategic acquisitions, bolster the positive sentiment. However, challenges in the Life Science segment and market share losses in certain product categories are notable concerns.

Company Guidance

During the call, Getinge provided guidance for the fiscal year 2025, aiming for an organic net sales growth of 2% to 5% based on 2024 net sales. The company reiterated its financial targets for 2024 to 2028, which include achieving an average adjusted EPS growth of at least 12%. Key performance indicators showed positive trends, with recurring revenue now accounting for 65% of sales and high-margin products making up about two-thirds of sales. In the second quarter, organic net sales grew by 4.1%, and order intake increased by 4.4%. Despite challenges from tariffs and currency fluctuations, Getinge improved its adjusted EBITA margin to 12%, with an underlying performance suggesting it could have been above 14% without these headwinds. The company also highlighted its solid financial position, with leverage below 2.5x EBITDA.

Solid Organic Growth

Net sales grew by 4.1% organically with positive development across all business areas and regions. Order intake increased by 4.4% organically, particularly strong in Acute Care Therapies and Surgical Workflows.

Improved Margins

Adjusted gross and EBITA margins improved due to acquisitions, price increases, and positive mix. The underlying EBITA margin would have been above 14% if not for tariffs and FX.

Strong Performance in Key Markets

Strong order intake in the U.S., China, and Germany, contributing positively to the overall performance.

Positive Regulatory and Quality Developments

Intra-aortic balloon catheter portfolio obtained EU MDR certificate. Positive trends in regulatory compliance and a decrease in field actions per million of net sales.

Paragonix Acquisition Success

Paragonix celebrated its 100th kidney transplant case and is trending ahead of expectations, contributing positively to group margins.

Getinge AB (GNGBY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GNGBY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 21, 2025	2025 (Q3)	- / -	0.001	―	―	―
Jul 18, 2025	2025 (Q2)	- / 0.20	0.176	13.07% (+0.02)
Apr 22, 2025	2025 (Q1)	- / 0.10	0.162	-36.42% (-0.06)
Jan 28, 2025	2024 (Q4)	- / 0.23	0.247	-8.50% (-0.02)
Oct 18, 2024	2024 (Q3)	- / <0.01	0.304	-99.67% (-0.30)
Jul 18, 2024	2024 (Q2)	- / 0.18	0.074	137.84% (+0.10)
Apr 22, 2024	2024 (Q1)	- / 0.16	0.206	-21.36% (-0.04)
Feb 01, 2024	2023 (Q4)	- / 0.25	0.19	30.00% (+0.06)
Oct 23, 2023	2023 (Q3)	- / 0.30	0.278	9.35% (+0.03)
Jul 18, 2023	2023 (Q2)	- / 0.07	0.225	-67.11% (-0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GNGBY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 18, 2025	$19.40	$20.78	+7.11%
Apr 22, 2025	$20.05	$19.01	-5.19%
Jan 28, 2025	$18.20	$20.08	+10.33%
Oct 18, 2024	$19.65	$18.65	-5.09%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Getinge AB (GNGBY) report earnings?

Getinge AB (GNGBY) is schdueled to report earning on Oct 21, 2025, Before Open (Confirmed).

What is Getinge AB (GNGBY) earnings time?

Getinge AB (GNGBY) earnings time is at Oct 21, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is GNGBY EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing